Zoetis Inc. (BMV:ZTS)

Market Cap	1.19T
Revenue (ttm)	176.98B
Net Income (ttm)	49.26B
Shares Out	n/a
EPS (ttm)	109.71
PE Ratio	24.12
Forward PE	22.32
Dividend	38.23 (1.40%)
Ex-Dividend Date	Jul 18, 2025

Volume	n/a
Average Volume	191
Open	2,737.11
Previous Close	2,737.11
Day's Range	2,737.11 - 2,737.11
52-Week Range	2,674.00 - 3,858.69
Beta	n/a
RSI	39.70
Earnings Date	Nov 3, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ZTS

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD